News Merck & Co boosted by Keytruda first-line lung cancer trial KEYNOTE-189 results could see US Merck tighten its grip in cancer immunotherapy.
News AZ's Lynparza becomes first PARP drug approved in breast can... Lynparza first in class approved in breast cancer
News Syndax announces further entinostat collaboration with Roche Syndax Pharmaceuticals has announced a new collaboration with Roche’s Genentech unit dedicated to combining small molecule cancer drug entinostat with the latter’s immunotherapy, Tecentriq.
Events Partner Content 3rd International Conference on Pancreatic Cancer and Liver ... Making Life Better: Fight Against Pancreatic Cancer
News UK offers meningitis jab to young people after outbreak The UK government has responded to calls to broaden vaccinations for meningitis B, offering the jab to "thousands" of young people this summer.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
